Interference No. 103378
k) quinoyl, optionally substituted with hydroxy, halo, nitro, cyano, C1-C12
alkyl, C1-C12 alkoxy, C1-C12 haloalkyl, C1-C12 hydroxyalkyl, C1-C12
alkylamino, di C1-C12 alkylamino, C1-C12 alkoxycarbonyl,
aminocarbonyl, C1-C12 alkylaminocarbonyl, di C1-C12
alkylaminocarbonyl and C1-C12 alkylsulfonyl;
Ar and B, together with the carbon atoms to which they are attached, may form
a ring;
n is O or 1;
m is O to 3;
p is 2 to 6; and
q is 1 or 2;
or
a pharmaceutical composition comprising a therapeutically effective amount of a
compound of formula I or a pharmaceutically acceptable salt thereof, and a
pharmaceutically acceptable
carrier.
or
a method of inhibiting the biosynthesis of leukotrienes comprising administering
to a mammal in need of such a treatment a therapeutical effective amount of a
compound of formula I.
The claims corresponding to count 3 are as follows:
Brooks: claims 1-11.
Hodgson: claims 1-7, 11-17, 21-34.
Ikeda: claims (as amended) 1-10, 13-19, 23-24, 27-28
and 32.
16
Page: Previous 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Last modified: November 3, 2007